** Resolor® (Prucalopride) 1 mg 28 film-coated tablets. Oral tablets.
** Each film-coated tablet contains:
1 mg prucalopride (equivalent to 1.321 mg prucalopride succinate)
** Prucalopride is a selective 5-HT4 receptor agonist with prokinetic properties. Resolor is indicated for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief.
Women: 2 mg once daily with or without food, at any time of the day.
Men, children and adolescents younger than 18 years: The safety and efficacy of Resolor for use in men has not been established in controlled clinical trials; therefore, Resolor is not recommended for use in these populations until further data becomes available.
– Renal impairment requiring dialysis.
– Intestinal perforation or obstruction due to structural or functional disorder of the gut wall, obstructive ileus, severe inflammatory conditions of the intestinal tract, such as Crohn’s disease, and ulcerative colitis and toxic megacolon/megarectum.
** Prescription only medicine (POM).
** For directions for use, see enclosed package insert.
** Do not store above 30 degrees C. Protect from moisture.
Keep out of reach of children.
** Manufactured, packaged and released by:
Janssen-Cilag S.p.A., Via C. Janssen, 04100 Borgo S. Michele, Latina – Italy
استيراد : جونسون اند جونسون
توزيع : سوفيكوفارم